“The attack on stem cell research has driven at least one regenerative medicine company to seek friendlier climes south of the border. Six months after the federal government forced it to stop its treatments, the Houston-based Celltex Therapeutics moved its operations to Mexico to avoid the long arm of the law. In moving to Mexico, Celltex enters a country where stem cell research is not as heavily regulated as in the U.S, though a facility is required to have an International Health Department Permit (COFEPRIS). The permit allocates the use of stem-cell types beyond those in the U.S.”
Related posts:
U.S. police seek 'blunt impact projectile' weapons
NSA has long role as top US locksmith, lock-picker
South Africa mine: Lonmin drops threat to fire workers
Hackers steal 2 billion rubles at Russia's central bank
Chicago police detain Americans at abuse-laden 'black site'
Horrific outrage erupts over proposed mosque in Virginia
American household income dropped nearly 5 percent in economic recovery
The Men Who Owned Bitcoin.com
Cyprus sees more stability, even bitcoin innovation
Help Thy Neighbor and Go Straight to Prison
American Airlines cutting 1,700 jobs in Tulsa, Fort Worth
Rent or buy a home? This map has the answer
Obamacare architect: High-deductible plans overdone
Secret NSA cybersecurity program to protect power grid confirmed
Barclays account shutdown raises Somali fears